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Abstract  
The only randomised controlled trial to test high fidelity assertive community 
treatment in the UK (the REACT Study) found no advantage over usual care from 
community mental health teams in reducing the need for inpatient care and other 
clinical outcomes, but participants found assertive community treatment more 
acceptable and engaged better with it.  One possible reason for the lack of efficacy of 
assertive community treatment might be the short period of follow up (18 months in 
the REACT study).  This paper reports on participants’ service contact, inpatient 
service use and adverse events 36 months after randomisation. 
 
Background 
Assertive Community Treatment (ACT) teams have been implemented across 
England since 1999 as part of the National Service Framework for Mental Health1.  
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These teams target people with severe and enduring mental health problems who 
are high users of inpatient care and have problems engaging with standard mental 
health services2.  There is good evidence for their clinical efficacy in the US and 
Australia3,4 in terms of reducing the need for inpatient care and associated costs.  
However, these advantages have not been replicated in the UK5,6.  A meta-analysis 
of trials of intensive case management concluded that the advantages of ACT were 
most evident where there was high local use of inpatient care and where the 
comparison intervention did not replicate key aspects of ACT7.  The Randomised 
Evaluation of Assertive Community Treatment in North London (REACT) study 
assessed outcomes 18 months after randomisation and found no clinical advantage 
over usual care from community mental health teams (CMHTs) but recipients of ACT 
were better engaged with services8.  Selection criteria for participants in the REACT 
study included high use of inpatient care and the comparison CMHTs had high 
fidelity for only one of the key ACT components (offering a time unlimited service)9.  
 
Another possible explanation for the REACT findings is that outcomes were 
assessed relatively soon after teams were set up. We therefore assessed outcomes 
36 months after randomisation to investigate whether reductions in inpatient service 
use might be evident following initial engagement with the service.  
 
Method 
The REACT study was carried out with full adherence to CONSORT guidelines for 
the management of randomised controlled trials.  The methods and results 18 
months after randomisation have been reported elsewhere8.  In brief, the 251 
participants were recruited from all CMHTs in the London boroughs of Camden and 
Islington between July 1999 and July 2002.  They were high users of inpatient care 
(at least 100 consecutive inpatient days or at least five admissions within the past two 
years; or at least 50 consecutive inpatient days or at least three admissions within the 
past year) who were living independently and whom the CMHTs had found 
problematic to engage over at least the previous 12 months.  There were no 
statistically significant differences between the two groups in clinical or social 
functioning at baseline.  Since including only consenting participants would render 
the results irrelevant to the service users most likely to be referred for ACT, the local 
research ethics committee approved randomisation and collection of case note and 
key informant data on all participants, whether or not they agreed to participate in the 
research interviews.  Participants were randomly allocated on an equal basis to the 
care of one of the two local ACT teams or to continue with their CMHT.  The fidelity 
of the ACT teams was independently assessed using the Dartmouth Assertive 
Community Treatment Scale10 during the REACT study and found to be high for one 
team and “ACT like” for the other11 and low for the CMHTs9. 
 
Approval for collection of 36 month outcome data from the case notes of all REACT 
study participants was gained from the local research ethics committee.  SK collected 
data on participants’ current accommodation, contact with services, inpatient service 
use, use of the Mental Health Act and adverse events (deaths, incidents of self-harm, 
violence, imprisonment, homelessness and loss to follow-up).  Data were collected 
from case notes except for three participants who had moved away. Their data were 
gathered from their new care co-ordinators by email or telephone.  Five ACT and 
seven CMHT files covering the relevant period were missing, and inpatient service 
use data were thus collected from the electronic records for these individuals.  Other 
data for these participants were collected directly from care co-ordinators except the 
number of face to face contacts which was recorded as missing. 
 
Data analysis 
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The REACT study required 250 participants to detect a difference in mean inpatient 
bed days (the primary outcome) of one third between the two interventions with 80% 
power.  Of 251 study participants recruited, 127 were allocated to ACT and 124 to 
CMHT care. Eighteen months after randomisation, three ACT and four CMHT 
participants had died and one CMHT participant had emigrated, so primary outcome 
data were available for 124 ACT and 119 CMHT participants. Thirty-six months after 
randomisation, a further three ACT and two CMHT participants had died and one 
ACT participant had emigrated. Hence 36 month outcome data were available for 
120 ACT and 117 CMHT participants.  At 36 month follow-up, 20 of the original ACT 
clients had been transferred back to the care of a CMHT and 20 of the CMHT clients 
had been transferred to an ACT team.  Data reported were analysed on an “intention 
to treat” basis, but repeat analyses excluding these clients and comparing all those 
who received any ACT with those who received none did not substantially alter the 
results. 
 
Since data were not normally distributed, the median inpatient service use was 
compared using the Mann-Whitney test.  Confidence intervals for the median 
difference were calculated using Hodges-Lehmann estimates.  Categorical data were 
compared using the Chi squared test, while Student’s t-test was used to compare 
normally distributed continuous variables. 
 
Results 
There were no statistically significant differences between the ACT and CMHT 
participants in total inpatient days over the 36 months (median difference = 0 [95% CI 
-50 to 56], Mann-Whitney test p=0.866).  Three ACT and three CMHT participants 
remained in hospital throughout the 36 months.  Fewer CMHT than ACT participants 
were admitted to a medium secure facility, but there were no other differences 
between the groups in any indicators of inpatient service use (Table 1).  Similar 
proportions were referred to supported accommodation. There were no statistically 
significant differences in adverse events between ACT and CMHT participants.  
When analysis was restricted to participants whose care had not transferred at the 
end of the REACT study, there was a statistically significant difference in the 
proportion of clients lost to follow-up (3/95 ACT vs 11/89 CMHT, 2 = 5.53, p = 0.019).  
The mean face to face contacts made between staff and clients over the preceding 
three months at 36 month follow-up was statistically significantly greater for ACT than 
CMHT participants (ACTT 12.20 [SD 12.05], CMHT 7.22 [SD 9.52], difference in 
means = 4.98 [95% CI 2.11 to 7.85], p=0.001).   
 
Discussion 
The main findings from this pragmatic follow-up study were that even over a longer 
period of intervention, the clinical gains for ACT clients and reductions in the need for 
inpatient service use demonstrated in the international literature were not replicated 
in the UK setting.  We used an “intention to treat” analysis of outcomes recorded in 
case notes and were able to report on 94% of the original REACT study participants.  
Our findings therefore appear robust.  The lack of effectiveness of ACT was not 
explained by CMHTs finding sources of extra support for their clients through referral 
to supported accommodation. 
 
The ACT teams made more face to face contacts with their clients in the previous 
three months than the CMHTs, and fewer ACT clients were lost to follow-up, 
although this difference failed to show statistical significance in the intention to treat 
analysis. It therefore appears that of the original aims identified for ACT2, only 
improved client engagement was achieved. 
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These findings concur with the 18 month outcomes reported in the REACT study8 
and national data on the impact of ACT teams on inpatient service use6.  
We conclude that in the UK, a longer period of ACT does not reduce the need for 
inpatient care and CMHTs are able to prevent admissions as successfully as ACT 
teams using fewer contacts.  Although ACT model fidelity was low for CMHTs, both 
types of service shared four of seven features identified as important for the success 
of intensive case management (primary clinical responsibility; based in the 
community; team leader doing clinical work; time-unlimited service)7.  This may partly 
explain our results.  It may also be that reducing the need for inpatient care is 
particularly difficult in areas with a high threshold for admission such as inner London.  
Further evaluation of ACT in the European context is needed to assist our 
understanding of the findings from the REACT studies.  In the meantime we question 
the continuing investment in ACT in the UK unless its greater acceptability to clients 
is very highly valued by policy makers and service commissioners.  
 
Table 1. Outcomes at 36 months for REACT study participants 
 
Inpatient service use ACTT 
N=120 
CMHT 
N=117 
 Mean (SD) Median IQR Mean (SD) Median IQR 
Total inpatient days 290.9 
(280.8) 
209.0 88.5 to 
422.8 
267.5 
(239.8) 
229.0 65.0 to 
443.0 
Number of admissions 
 
2.0 (1.8) 2.0 0 to 3.0 2.1 (2.1) 2.0 0 to 3.0 
Days per admission 107.8 
(151.7) 
55.5 0 to 
166.5 
117.8 
(136.8) 
87.0 0 to 
173.5 
Involuntary admissions 
 
1.4 (1.3) 1.0 0 to 2.0 1.5 (1.4) 1.0 0 to 2.5 
 ACTT  
N=120 
CMHT 
N=117 
2 P 
No admissions   31 (26%)  34 (29%)  
1.659 
 
0.646 1 admission  25 (22%) 17 (15%) 
2 admissions 22 (18%) 23 (20%) 
>2 admissions 42 (35%) 43 (37%) 
Involuntary admission/s 79 (88%) 79 (92%) 0.076 0.783 
PICU admission/s 32 (36%) 34 (40%) 0.169 0.681 
MSU/special hospital 
admission/s 
10 (11%) 2 (2%) 5.407 0.020 
Adverse incidents 
 
    
Lost to follow up*  
ACTT n=114  
CMHT n=109 
5 (4) 12 (11) 3.465 0.062 
Homelessness 
 
17 (19) 20 (22) 0.385 0.385 
Physical assault   
 
34 (28)  
[1 homicide] 
25 (21)  
  
1.537 0.215 
Arson 
 
10 (8) 6 (5) 0.832 0.362 
Self-harm  
ACTT n = 127  
CMHT = 124 
15 (12) 
[of which 1 was 
a suicide] 
19 (15)  
[of which 3 
were suicides] 
0.661 0.416 
Prison 
 
10 (8) 9 (8) 0.033 0.856 
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Accommodation 
 
    
Independent tenancy 
 
88 (83) 
 
88 (81) 
 
 
 
1.491 
 
 
0.828 Floating support 
 
6 (5) 
 
9 (8) 
 
Supported tenancy 
 
4 (3) 
 
3 (2) 
 
Residential care 
 
9 (8) 8 (7) 
In hospital or prison 
 
13 (11) 9 (8) 
*defined as no face to face contacts between staff and client in previous three 
months  
MSU= medium secure unit 
PICU = psychiatric intensive care unit 
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